PomDoctor Ltd. (POM) Financial Statements

Income statement

Metric	2025	2024	2023	2022
Revenue
Total Revenue	399.9M	342.6M	304.9M	245.2M
Cost of Revenue	347.6M	294.9M	266.1M	190.4M
Gross Profit	52.3M	47.7M	38.7M	54.9M
Operating Expenses
R&D Expense	12.9M	3.0M	3.4M	3.6M
SG&A Expense	155.9M	68.2M	56.0M	54.9M
General & Admin Expense	59.7M	11.9M	12.3M	7.4M
Selling & Marketing Expense	96.2M	56.4M	43.7M	47.5M
Other Expenses	(152.6K)	2.2M	1.6M	—
Total Operating Expenses	168.7M	73.5M	61.0M	58.5M
Cost and Expenses	516.3M	368.3M	327.1M	248.8M
Operating Income (EBIT)	(116.4M)	(25.8M)	(22.2M)	(3.6M)
Non-Operating
Interest Income	—	—	—	—
Interest Expense	12.9M	13.0M	13.8M	16.0M
Net Interest Income	(12.9M)	(13.0M)	(13.8M)	(16.0M)
Other Non-Op Income/Expense	(14.6M)	(11.6M)	(14.7M)	(16.2M)
Non-Operating Income (excl Interest)	1.7M	(1.4M)	851.4K	214.4K
EBT (Pre-Tax Income)	(130.9M)	(37.4M)	(36.9M)	(19.8M)
Income Tax Expense	375.00	—	—	—
Bottom Line
Net Income	(212.6M)	(143.4M)	(145.4M)	(125.5M)
Earnings from Cont. Ops	(130.9M)	(37.4M)	(36.9M)	(19.8M)
Earnings from Discont. Ops	—	—	—	—
Bottom Line Net Income	(212.6M)	(143.4M)	(145.4M)	(125.5M)
Per Share
Basic EPS	($3.66)	($21.78)	($22.14)	($19.08)
Diluted EPS	($3.66)	($21.78)	($22.14)	($19.08)
Revenue Per Share	$6.89	$52.06	$46.33	$37.27
Shares
Basic Shares Outstanding	58.1M	6.6M	6.6M	6.6M
Diluted Shares Outstanding	58.1M	6.6M	6.6M	6.6M
Profitability Metrics
EBITDA	(117.9M)	(24.3M)	(23.0M)	(3.8M)
D&A	149.3K	134.5K	112.1K	—
EBIT	(118.0M)	(24.4M)	(23.1M)	(3.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025